SGRL629.00

Shree Ganesh Remedies Limited

· Pharma & Health
₹ CrorePeersBPLPHARMAJENBURPHKPLMAKERSLNOVARTINDPARNAXLABSHUKRAPHARSUNLOC
View
In ₹ Crore except Per Share
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Adjustments to Reconcile Profit — Non-cash Items
+ Depreciation & Amortisation9.610.5
+ Finance Costs2.13.6
+ Interest Income-0.0-0.1
+ Unrealised FX (Gain) / Loss0.3-1.6
Changes in Working Capital
+ Inventories3.0-2.0
+ Trade Receivables — Current-1.5-9.4
+ Trade Payables — Current-2.23.5
Cash from Operating Activities
Profit Before Tax (per I/S)38.231.324.0
+ Income Taxes Paid10.14.8
Cash from Operating Activities30.723.8
Cash from Investing Activities
+ Disp of Fixed Assets0.00.0
+ Interest Received — Investing0.00.1
Cash from Investing Activities-35.7-9.9
Cash from Financing Activities
Cash from Financing Activities-1.1-11.7
Net Changes in Cash-6.12.2
Closing Cash9.913.4
Reference Items
EBITDA41.839.235.0
EBITDA Margin %33.2136.1132.04
Free Cash Flow (CFO − Capex)30.723.8
Cash Flow to Net Income1.331.34
Cash Paid for Taxes10.14.8
As filed, sign as filed: a payment tagged as a positive magnitude in the filing stays positive here, so read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown — depth follows the filer, so a thin statement means a thin filing. Total Adjustments is the filer's own grand total of the reconciliation and spans BOTH the non-cash items and the working-capital block; Profit Before Tax plus it equals Cash from Operations (pre-tax). It can be reported when its components are not, so it is never a sum of the rows above it. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 85%.